Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Companion Animal Health Market Size, Share & Trends Analysis Report by Animal, Product, Distribution Channel, End-use, Region, and Segment...
-
March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates...
-
Vancouver, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Global Power Solutions Corp. (TSXV: PWER) (FSE: NJA) (“Global” or the “Company”) announces that it has joined the Canada Data Centres’...
-
Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development.
-
Washington, D.C., March 24, 2026 (GLOBE NEWSWIRE) -- The New Civil Liberties Alliance, on behalf of its clients Jill Hines and Dr. Aaron Kheriaty, has reached a settlement agreement and Consent...
-
Belleville, Illinois, March 24, 2026 (GLOBE NEWSWIRE) -- During Brain Injury Awareness Month, Allsup, the nation’s leading provider of Social Security Disability Insurance (SSDI) representation is...
-
TB therapeutics market grows to USD 3.95 Bn by 2035, driven by MDR/XDR cases, innovation, funding support, and rising demand across high-burden regions.
-
OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with...
-
PITTSBURGH, PA, March 23, 2026 (GLOBE NEWSWIRE) -- Today, Niche released its 2026 Best Places to Live in America rankings, highlighting notable shifts across the country, including seven new places...
-
Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...